Clinical utility of plecanatide in the treatment of chronic idiopathic constipation

Keyphrases

• Functional Constipation 100%
• Constipation 100%
• Clinical Utility 100%
• Plecanatide 100%
• Synthetic Peptides 20%
• Chemoprevention 20%
• Cyclic GMP 20%
• Quality of Life 20%
• CGMP Signaling 20%
• Clinical Efficacy 20%
• Colorectal Cancer 20%
• Signal Component 20%
• Functional Bowel Disorders 20%
• Diarrhea 20%
• Unknown Etiology 20%
• Linaclotide 20%
• Enterotoxin 20%
• Ulcerative Colitis 20%
• Phosphodiesterase Inhibitors 20%
• Guanylyl Cyclase C 20%
• Health Burden 20%
• Guanylyl Cyclase C Agonists 20%
• Reduced Side Effects 20%
• Uroguanylin 20%
• Diarrheagenic 20%
• Peptide Agonist 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Constipation 100%
• Plecanatide 100%
• Side Effect 50%
• Symptom 16%
• Clinical Study 16%
• Colorectal Cancer 16%
• Guanylate Cyclase 16%
• Synthetic Peptide 16%
• Enteropathy 16%
• Preclinical Study 16%
• Diarrhea 16%
• Linaclotide 16%
• Ulcerative Colitis 16%
• Phosphodiesterase Inhibitor 16%
• Heat Stable Enterotoxin Receptor Agonist 16%
• Uroguanylin 16%
• Enterotoxin 16%

Biochemistry, Genetics and Molecular Biology

• Agonist 100%
• Guanylate Cyclase 100%
• Phosphodiesterase 50%
• Enterotoxin 50%
• Preclinical Study 50%
• Linaclotide 50%
• Uroguanylin 50%